Coronavirus (COVID-19) Highest Risk (formerly Shielding) List end: equality and fairer Scotland impact assessment

This presents an assessment of any differential impact on each of the protected characteristics of the decision to end Scotland’s Covid Highest Risk List, formerly the Shielding List and considers any possible inequality of outcomes of the policy due to socio-economic differences.

3. Current Clinical Advice

3.1 There is now a far better understanding of the range of risk factors that may put an individual at increased risk of becoming seriously unwell from COVID-19. In addition, the evidence on the effectiveness of vaccines for people on the Highest Risk List (HRL), coupled with the availability and efficacy of new treatments such as antivirals, immune modulators and monoclonal antibodies, have changed the context significantly.

3.2 We have seen significant improvements in outcomes since vaccination for the majority of people on the HRL and this is also seen, although to a lesser extent, within people who are immunosuppressed or immunocompromised. While vaccine efficacy may not be as high for all people on the HRL, it still provides a good level of protection from becoming severely ill or dying.

3.3 The evidence for this decision is set out in the 'Review of the Evidence for Scottish Government Advice to People on the Scotland's Highest Risk List'[4].



Back to top